Pliant Therapeutics (PLRX) Treasury Shares (2019 - 2026)
Pliant Therapeutics (PLRX) posted quarterly Treasury Shares of $557456.0 for Q1 2026, down 58.62% year-over-year from $1.3 million in Q1 2025, and down 35.05% quarter-over-quarter from $858247.0 in Q4 2025.
Pliant Therapeutics (PLRX) Treasury Shares (2019 - 2026) Analysis & Trends
Pliant Therapeutics (PLRX) has reported Treasury Shares for 8 consecutive years, with $557456.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares fell 58.62% year-over-year to $557456.0; the TTM figure through Mar 2026 stood at $557456.0 (down 58.62% YoY), while the FY2025 annual figure was $858247.0, down 7.98% from the prior year.
- Treasury Shares retreated to $557456.0 in Q1 2026 per PLRX's latest filing, from $858247.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $1.3 million in Q1 2025 and bottomed at $6235.0 in Q1 2022.
- Historically, Treasury Shares has averaged $831280.2 across 5 years, with a median of $924671.0 in 2023.
- Annual changes were most pronounced in 2023 — Treasury Shares surged 18641.56% — and 2026, when it plunged 58.62%.
- Pliant Therapeutics' Treasury Shares stood at $354532.0 in 2022, then surged by 146.73% to $874748.0 in 2023, then climbed by 6.62% to $932634.0 in 2024, then declined by 7.98% to $858247.0 in 2025, then slumped by 35.05% to $557456.0 in 2026.
- Business Quant data shows PLRX's Treasury Shares at $557456.0 in Q1 2026, $858247.0 in Q4 2025, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.20 Bn | 131.35 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.09 Bn | 78.10 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 65.25 Bn | 60.07 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.04 Bn | 53.90 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.04 Bn | 36.94 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.04 Bn | 9.65 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.50 Bn | 26.33 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.34 Bn | 26.50 Bn | - | 2.72 Mn |
| 10 | Pliant Therapeutics | 71.21 Mn | 71.21 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 524,714.00 |
| Jun 30, 2026 | 524,714.00 |
| Mar 31, 2026 | 557,456.00 |
| Mar 31, 2026 | 557,456.00 |
| Dec 31, 2025 | 858,247.00 |
| Dec 31, 2025 | 858,247.00 |
| Sep 30, 2025 | 1.01 Mn |
| Sep 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | 1.06 Mn |
| Mar 31, 2025 | 1.35 Mn |
| Mar 31, 2025 | 1.35 Mn |
| Dec 31, 2024 | 932,634.00 |
| Dec 31, 2024 | 932,634.00 |
| Sep 30, 2024 | 951,127.00 |
| Sep 30, 2024 | 951,127.00 |
| Jun 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | 1.18 Mn |
| Mar 31, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.20 Mn |